FABP5 and cancer: Taken together, our study made a pan-cancer analysis of FABP5 on the basis of the clinical data from The Cancer Genome Atlas (TCGA) database for the first time, and observed novel FABP5-related regulatory networks in kidney renal clear cell carcinoma (KIRC) and liver hepatocellular carcinoma (LIHC).